214 related articles for article (PubMed ID: 12672195)
1. Hypothesis: pathogenesis of systemic sclerosis.
Takehara K
J Rheumatol; 2003 Apr; 30(4):755-9. PubMed ID: 12672195
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis.
Ikawa Y; Ng PS; Endo K; Kondo M; Chujo S; Ishida W; Shirasaki F; Fujimoto M; Takehara K
J Cell Physiol; 2008 Sep; 216(3):680-7. PubMed ID: 18481257
[TBL] [Abstract][Full Text] [Related]
4. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis.
Leask A
Keio J Med; 2004 Jun; 53(2):74-7. PubMed ID: 15247510
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.
Hong KH; Yoo SA; Kang SS; Choi JJ; Kim WU; Cho CS
Clin Exp Immunol; 2006 Nov; 146(2):362-70. PubMed ID: 17034590
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis.
Denton CP; Abraham DJ
Curr Opin Rheumatol; 2001 Nov; 13(6):505-11. PubMed ID: 11698729
[TBL] [Abstract][Full Text] [Related]
8. Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma.
Leask A
Cell Signal; 2008 Aug; 20(8):1409-14. PubMed ID: 18296024
[TBL] [Abstract][Full Text] [Related]
9. Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis.
Ihn H
J Dermatol Sci; 2008 Feb; 49(2):103-13. PubMed ID: 17628443
[TBL] [Abstract][Full Text] [Related]
10. Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis.
Qi W; Twigg S; Chen X; Polhill TS; Poronnik P; Gilbert RE; Pollock CA
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F800-9. PubMed ID: 15536170
[TBL] [Abstract][Full Text] [Related]
11. Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1.
Holmes A; Abraham DJ; Chen Y; Denton C; Shi-wen X; Black CM; Leask A
J Biol Chem; 2003 Oct; 278(43):41728-33. PubMed ID: 12888575
[TBL] [Abstract][Full Text] [Related]
12. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model.
Mori T; Kawara S; Shinozaki M; Hayashi N; Kakinuma T; Igarashi A; Takigawa M; Nakanishi T; Takehara K
J Cell Physiol; 1999 Oct; 181(1):153-9. PubMed ID: 10457363
[TBL] [Abstract][Full Text] [Related]
13. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.
Shi-wen X; Pennington D; Holmes A; Leask A; Bradham D; Beauchamp JR; Fonseca C; du Bois RM; Martin GR; Black CM; Abraham DJ
Exp Cell Res; 2000 Aug; 259(1):213-24. PubMed ID: 10942593
[TBL] [Abstract][Full Text] [Related]
14. The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma.
Ihn H
Arch Immunol Ther Exp (Warsz); 2002; 50(5):325-31. PubMed ID: 12455866
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma.
Zhou X; Tan FK; Guo X; Arnett FC
Arthritis Rheum; 2006 Aug; 54(8):2626-31. PubMed ID: 16871529
[TBL] [Abstract][Full Text] [Related]
16. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.
Holmes A; Abraham DJ; Sa S; Shiwen X; Black CM; Leask A
J Biol Chem; 2001 Apr; 276(14):10594-601. PubMed ID: 11152469
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta pathway is activated in cholecystolithiasis.
Köninger J; di Mola FF; Di Sebastiano P; Gardini A; Brigstock DR; Innocenti P; Büchler MW; Friess H
Langenbecks Arch Surg; 2005 Feb; 390(1):21-8. PubMed ID: 15702358
[TBL] [Abstract][Full Text] [Related]
18. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders.
Igarashi A; Nashiro K; Kikuchi K; Sato S; Ihn H; Fujimoto M; Grotendorst GR; Takehara K
J Invest Dermatol; 1996 Apr; 106(4):729-33. PubMed ID: 8618012
[TBL] [Abstract][Full Text] [Related]
19. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis.
Igarashi A; Nashiro K; Kikuchi K; Sato S; Ihn H; Grotendorst GR; Takehara K
J Invest Dermatol; 1995 Aug; 105(2):280-4. PubMed ID: 7636314
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice.
Inoue T; Okada H; Kobayashi T; Watanabe Y; Kanno Y; Kopp JB; Nishida T; Takigawa M; Ueno M; Nakamura T; Suzuki H
FASEB J; 2003 Feb; 17(2):268-70. PubMed ID: 12475893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
